<unk>  is metabolized by CYP3A4 and CYP3A5, so substances that strongly inhibit either enzyme, like macrolide antibiotics, antifungals, and antivirals may increase exposure to<unk> , and substances like rifampicin that activate either enzyme may decrease the effectiveness of<unk> .
Osimertinib
Mobocertinib
Lestaurtinib
Upadacitinib
Abrocitinib
Axitinib
Selpercatinib
Icotinib